Home
News
296
Results found
-
2000th patient milestone reached in MOMENTUM study
MOMENTUM, a study focused on tracking the outcomes of combining Magnetic Resonance (MR) and Radiation Therapy (RT) to treat various types of cancer, has successfully enrolled 2000 patients. -
PERSIST-SEQ: International research consortium aims to build a reproducible single-cell sequencing workflow to capture tumour persistence
Lygature was instrumental in the set-up phase of the PERSIST-SEQ consortium. In close collaboration with the Oncode Institute, Lygature supported the entire two-stage application process, followed by the preparation of the final proposal (Grant Agreement). Lygature supports the PERSIST-SEQ consortium by providing partnership management as well as communication and dissemination expertise. -
NWO is putting BBMRI.nl into the spotlights
The Dutch NWO magazine ‘Onderzoek’, interviewed Nine Knoers and Lygature's program manager Tieneke Schaaij-Visser to explain the role of BBMRI.nl in maximizing the use of biosamples, images and data for health research -
“Welcome!” to our new colleagues - Tessa Sandberg and Irina Stoica
We are happy to welcome Tessa and Irina to our team! You can meet them below and find out more about their background, expertise and new responsibilities within the Lygature team. -
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched. -
Health-RI kicks-off growth fund trajectory
Health-RI is preparing to quickly take the necessary steps forward now the Dutch cabinet has selected Health-RI's National Growth Fund proposal for a national health data infrastructure. -
The RADAR-AD consortium publishes a paper which reviews EMA’s recent scientific advices and opinions for RMTs
Within the RADAR-AD consortium Lygature is responsible for the project management, communication about the study and dissemination of its results to relevant stakeholders, as well as communications with regulatory authorities, patient associations, payers and ethical boards. -
Vacancy: Program Manager
We are currently accepting applications for the position of Program Manager (32-40 hrs p/week) -
The MLC Foundation and Lygature sign collaboration agreement
As of June 1st, 2021, the MedLaw Consult Foundation (MLCF) and Foundation Lygature have entered into a collaboration agreement to combine their expertise to facilitate medical research. The collaboration allows both organisations to build upon their complementary strengths. -
Day of the African Child 2021
Today – International Day of the African Child – we celebrate the rights of children to a good quality of life and a healthy, prosperous future. -
Lygature supports request for a National Genome Programme for health
A broadly supported alliance of practitioners, researchers, professional associations, and patient organizations points out the importance of involving genetic data in prevention, diagnosis and care. -
Thesis defense PhD candidate Renske ten Ham (UU): "Development, market authorization and market access of gene and cell-based therapies"
On 4 June 2021 at 2:15pm PhD candidate Renske ten Ham from Utrecht University will defend her thesis titled: "Development, market authorization and market access of gene and cell-based therapies". -
Celebrating 50 years of PALGA
To celebrate the 50th anniversary of PALGA, the Dutch network and registry of histo- and cytopathology, the Dutch Society for Pathology (NvvP) published a special issue of their ‘NVVP Magazine’. -
Forging partnerships to tackle the global health challenges of today and tomorrow
An interview with Kristina Orrling and Remco de Vrueh -
GNA NOW Open Call webinar recording now available
During two webinar sessions held on 12 and 26 May, GNA NOW Project Lead Eric Bacqué (Evotec) and Project Coordinator Kristina Orrling (Lygature) presented on the GNA NOW Open Call.